文献速递重症综合管理与镇静镇痛儿科与产科急症创伤与烧伤

不同镇静方案对多发伤危重患儿镇静及炎症反应的影响

[Effects of different sedation regimens on sedation and inflammatory response in critically ill children with multiple trauma].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论与咪达唑仑相比,右美托咪定用于多发伤危重患儿可降低促炎因子、缩短机械通气与PICU停留时间并降低脓毒症比例,但CRRT比例、MOF与病死率无显著差异。

该前瞻性随机对照试验纳入2014年1月至2016年9月安徽省儿童医院PICU收治的65例多发伤危重患儿,随机分为右美托咪定组(33例)与咪达唑仑组(32例),两组均以舒芬太尼镇痛,镇静目标为RASS评分-1至0。右美托咪定组先以1.0 μg/kg静脉负荷10分钟,随后以0.2-0.7 μg×kg-1×h-1持续泵入;咪达唑仑组以1-5 μg×kg-1×min-1持续泵入。结果显示右美托咪定组在24、48、72小时多个时点降低IL-1β、TNF-α、IL-6、IL-8、CRP并升高IL-10,缩短机械通气时间(4.7±1.3天 vs 6.6±2.1天)与PICU停留时间(9.5±2.7天 vs 12.3±3.9天),脓毒症比例更低(33.3% vs 53.1%),但CRRT比例、MOF比例与病死率无显著差异。

要点

  • 右美托咪定组机械通气时间4.7±1.3天 vs 咪达唑仑组6.6±2.1天,PICU停留时间9.5±2.7天 vs 12.3±3.9天,均P<0.05。
  • 右美托咪定组脓毒症比例33.3% vs 咪达唑仑组53.1%(P<0.05),CRRT比例18.2% vs 18.8%、MOF比例9.1% vs 18.8%、病死率6.1% vs 12.5%均无显著差异(均P>0.05)。
  • 治疗48小时右美托咪定组IL-6 209.67±80.49 ng/L vs 咪达唑仑组336.31±123.94 ng/L、IL-8 229.09±80.81 ng/L vs 298.28±90.25 ng/L、CRP 47.82±24.92 g/L vs 72.35±31.71 g/L,均P<0.05。
  • 方案:右美托咪定1.0 μg/kg静脉负荷10分钟后以0.2-0.7 μg×kg-1×h-1持续泵入;咪达唑仑1-5 μg×kg-1×min-1持续泵入;两组均用舒芬太尼镇痛,镇静目标RASS评分-1至0。

适用人群与场景

  • 2014年1月至2016年9月安徽省儿童医院PICU收治的多发伤危重患儿65例,年龄、性别等基线原文未报告。

诊断标准与关键阈值

  • 镇静目标为维持Richmond躁动-镇静评分(RASS)-1至0分。

处置流程与药物剂量

  • 两组患儿均接受舒芬太尼镇痛(剂量原文未写明)。
  • 右美托咪定组:先以1.0 μg/kg静脉负荷10分钟,随后以0.2-0.7 μg×kg-1×h-1持续静脉泵入。
  • 咪达唑仑组:以1-5 μg×kg-1×min-1持续静脉泵入。
  • 镇静目标:维持RASS评分-1至0分。

研究设计与关键结果

  • 研究类型:前瞻性随机对照试验;样本量65例,右美托咪定组33例、咪达唑仑组32例;单中心(安徽省儿童医院PICU)。
  • 主要炎症指标:治疗24小时,右美托咪定组IL-1β 6.48±2.89 ng/L vs 咪达唑仑组8.07±3.14 ng/L、TNF-α 11.25±5.21 μg/L vs 15.44±5.97 μg/L均显著降低,IL-10 12.10±5.35 ng/L vs 9.58±4.71 ng/L显著升高(均P<0.05)。
  • 治疗48小时,右美托咪定组IL-6 209.67±80.49 ng/L vs 336.31±123.94 ng/L、IL-8 229.09±80.81 ng/L vs 298.28±90.25 ng/L、IL-1β 7.31±3.02 ng/L vs 8.74±3.17 ng/L、TNF-α 12.52±4.79 μg/L vs 16.58±5.98 μg/L、CRP 47.82±24.92 g/L vs 72.35±31.71 g/L均显著降低,IL-10 12.90±5.42 ng/L vs 10.01±4.79 ng/L显著升高(均P<0.05)。
  • 治疗72小时,右美托咪定组IL-8 234.64±96.24 ng/L vs 290.28±103.97 ng/L、CRP 53.24±29.12 g/L vs 86.58±38.30 g/L显著降低(均P<0.05)。
  • 临床结局:右美托咪定组机械通气时间4.7±1.3天 vs 咪达唑仑组6.6±2.1天、PICU停留时间9.5±2.7天 vs 12.3±3.9天、脓毒症比例33.3% vs 53.1%均显著降低(均P<0.05)。
  • CRRT比例18.2% vs 18.8%、MOF比例9.1% vs 18.8%、病死率6.1% vs 12.5%两组比较均无显著差异(均P>0.05)。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与咪达唑仑相比,右美托咪定治疗儿童严重多发伤疗效更好并可降低炎症水平。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the sedation and anti-inflammatory effects of dexmedetomidine and midazolam on critical ill children with multiple trauma.

METHODS: A prospective randomized controlled trial was conducted. Sixty-five critical ill children with multiple trauma admitted to pediatric intensive care unit (PICU) of Anhui Province Children's Hospital from January 2014 to September 2016 were enrolled, who were randomly divided into dexmedetomidine group (33 cases) and midazolam group (32 cases). Children of both groups received sufentanil for analgesia. Children in dexmedetomidine group firstly received 1.0 μg/kg intravenous bolus of dexmedetomidine for 10 minutes, then continuous infusion of 0.2-0.7 μg×kg-1×h-1, while in midazolam group children received 1-5 μg×kg-1×min-1 of midazolam in continuous infusion. The goal of sedation was to maintain a Richmond agitation-sedation scale (RASS) score of -1 to 0. The level of serum interleukin (IL-6, IL-8, IL-10, IL-1β), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP) were detected by enzyme linked immunosorbent assay (ELISA) at 24, 48, 72 hours after treatment, and the duration of mechanical ventilation, ratio of continuous renal replacement therapy (CRRT), length of stay in the PICU, ratio of sepsis and multiple organ failure (MOF) and mortality were also recorded.

RESULTS: Compared with midazolam, dexmedetomidine decreased the level of pro-inflammatory cytokines and increased the level of anti-inflammatory cytokines. At 24 hours after treatment, the levels of serum IL-1β, TNF-α significantly decreased and IL-10 significantly increased [IL-1β (ng/L): 6.48±2.89 vs. 8.07±3.14, TNF-α (μg/L): 11.25±5.21 vs. 15.44±5.97, IL-10 (ng/L): 12.10±5.35 vs. 9.58±4.71, all P < 0.05]. At 48 hours after treatment, the levels of serum IL-6, IL-8, IL-1β, TNF-α and CRP significantly decreased and IL-10 significantly increased [IL-6 (ng/L): 209.67±80.49 vs. 336.31±123.94, IL-8 (ng/L): 229.09±80.81 vs. 298.28±90.25, IL-1β (ng/L): 7.31±3.02 vs. 8.74±3.17, TNF-α (μg/L): 12.52±4.79 vs. 16.58±5.98, CRP (g/L): 47.82±24.92 vs. 72.35±31.71, IL-10 (ng/L): 12.90±5.42 vs. 10.01±4.79, all P < 0.05]. At 72 hours after treatment, the levels of serum IL-8 and CRP significantly decreased [IL-8 (ng/L): 234.64±96.24 vs. 290.28±103.97, CRP (g/L): 53.24±29.12 vs. 86.58±38.30, both P < 0.05]. Compared with midazolam, dexmedetomidine could significantly reduce the duration of mechanical ventilation (days: 4.7±1.3 vs. 6.6±2.1), length of PICU stay (days: 9.5±2.7 vs. 12.3±3.9, both P < 0.05), and the ratio of sepsis (33.3% vs. 53.1%, P < 0.05). But there were no significant differences in ratio of CRRT (18.2% vs. 18.8%), MOF (9.1% vs. 18.8%) and mortality (6.1% vs. 12.5%) between two groups (all P > 0.05).

CONCLUSIONS: Compared with midazolam, dexmedetomidine had better efficacy in the treatment of severe multiple trauma in children and reduce the level of inflammation.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Tong W, Song C, Jin D, et al. [Effects of different sedation regimens on sedation and inflammatory response in critically ill children with multiple trauma]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28625245. doi:10.3760/cma.j.issn.2095-4352.2017.06.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。